Antifolate resistance due to new and known Plasmodium falciparum dihydrofolate reductase mutations expressed in yeast (Q47836741)

6 February 2018

title

Antifolate resistance due to new and known Plasmodium falciparum dihydrofolate reductase mutations expressed in yeast (English)

1 reference

6 February 2018

main subject

Plasmodium falciparum

1 reference

Cortese JF

1

1 reference

6 February 2018

Plowe CV

series ordinal

2

1 reference

6 February 2018

publication date

1 August 1998

1 reference

6 February 2018

Molecular and Biochemical Parasitology

published in

1 reference

6 February 2018

volume

94

1 reference

6 February 2018

issue

2

1 reference

6 February 2018

page(s)

205-214

1 reference

6 February 2018

Chlorproguanil-dapsone: effective treatment for uncomplicated falciparum malaria.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2898%2900075-9

7 January 2021

Atovaquone and proguanil for Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2898%2900075-9

7 January 2021

Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2898%2900075-9

7 January 2021

Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2898%2900075-9

7 January 2021

Transformation of Plasmodium falciparum malaria parasites by homologous integration of plasmids that confer resistance to pyrimethamine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2898%2900075-9

7 January 2021

Prevalence of the dihydrofolate reductase Asn-108 mutation as the basis for pyrimethamine-resistant falciparum malaria in the Brazilian Amazon.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2898%2900075-9

7 January 2021

Community pyrimethamine-sulfadoxine use and prevalence of resistant Plasmodium falciparum genotypes in Mali: a model for deterring resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2898%2900075-9

7 January 2021

Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2898%2900075-9

7 January 2021

Analysis in yeast of antimalaria drugs that target the dihydrofolate reductase of Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2898%2900075-9

7 January 2021

Activity of PS-15 and its metabolite, WR99210, against Plasmodium falciparum in an in vivo-in vitro model

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2898%2900075-9

7 January 2021

Transformation with human dihydrofolate reductase renders malaria parasites insensitive to WR99210 but does not affect the intrinsic activity of proguanil

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2898%2900075-9

7 January 2021

Pyrimethamine and Proguanil Resistance-Conferring Mutations in Plasmodium falciparum Dihydrofolate Reductase: Polymerase Chain Reaction Methods for Surveillance in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2898%2900075-9

7 January 2021

In vitro antimalarial activity of tetrahydrofolate dehydrogenase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2898%2900075-9

7 January 2021

Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2898%2900075-9

7 January 2021

10.1016/S0166-6851(98)00075-9

Identifiers

DOI

1 reference

6 February 2018

1 reference

6 February 2018